The role of galactosyltransferases in cell surface functions and in the immune system

被引:24
作者
Brockhausen, Inka
机构
[1] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Med, Human Mobil Res Ctr, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1358/dnp.2006.19.7.1021491
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The immune system relies on cellular communication and often on the recognition of carbohydrates by mammalian lectins. Galactose (Gal)-containing structures are involved in both the innate and adaptive immune systems. Gal is a ligand for Gal/N-acetylgalactosmine (GalNAc) receptors and galectins, and is part of the scaffold structure that synthesizes oligosaccharide ligands for selectins, siglecs and other lectins of the immune system. Gal residues are added to glycoproteins and glycolipids by members of a large family of galactosyltransferases. The expression of many of these enzymes is regulated by the action of cytokines, and becomes altered in various disease states. Specific galactosyltransferases have been shown to control cell adhesion and leukocyte functions. Antibodies need to be galactosylated for normal function, and undergalactosylated immunoglobulin (lg) is associated with rheumatoid arthritis, while Gal is lacking in the IgA of patients with IgA nephropathy. Interactions involving Gal play important roles in host defenses; they can also result in serious pathophysiology' Galactosyltransferases represent potential targets for the control of cell growth and apoptosis, inflammation and infections. (C) 2006 Prous Science. All rights reserved.
引用
收藏
页码:401 / 409
页数:9
相关论文
共 77 条
[21]   Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1 [J].
Galvan, M ;
Tsuboi, S ;
Fukuda, M ;
Baum, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16730-16737
[22]   Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes [J].
García-Vallejo, JJ ;
Van Dijk, W ;
Hof, BV ;
Van Die, I ;
Engelse, MA ;
Van Hinsbergh, VWM ;
Gringhuis, SI .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 206 (01) :203-210
[23]   Bovine α1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases [J].
Gastinel, LN ;
Bignon, C ;
Misra, AK ;
Hindsgaul, O ;
Shaper, JH ;
Joziasse, DH .
EMBO JOURNAL, 2001, 20 (04) :638-649
[24]  
Goletz S, 1997, J CELL SCI, V110, P1585
[25]   Deficiency of UDP-galactose:N-acetylglucosamine β-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId [J].
Hansske, B ;
Thiel, C ;
Lübke, T ;
Hasilik, M ;
Höning, S ;
Peters, V ;
Heidemann, PH ;
Hoffmann, GF ;
Berger, EG ;
von Figura, K ;
Körner, C .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (06) :725-733
[26]   The galactosyltransferase family [J].
Hennet, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (07) :1081-1095
[27]   Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity [J].
Holgersson, Jan ;
Lofling, Jonas .
GLYCOBIOLOGY, 2006, 16 (07) :584-593
[28]   Mucins in cancer: Protection and control of the cell surface [J].
Hollingsworth, MA ;
Swanson, BJ .
NATURE REVIEWS CANCER, 2004, 4 (01) :45-60
[29]   The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G [J].
Jeddi, P ;
Keusch, J ;
Lydyard, PM ;
Bodman-Smith, KB ;
Chesnutt, MS ;
Wofsy, D ;
Hirota, H ;
Taga, T ;
Delves, PJ .
IMMUNOLOGY, 1999, 98 (03) :475-480
[30]   Protein glycosylation - Chaperone mutation in Tn syndrome [J].
Ju, TZ ;
Cummings, RD .
NATURE, 2005, 437 (7063) :1252-1252